Bexion Pharmaceuticals advances BXQ-350 cancer drug trial with phase 1 part 3 launch

Bexion Pharmaceuticals has launched part 3 of its phase 1 clinical trial for BXQ-350, an investigational cancer treatment aimed at advancing the fight against solid ... Read More